About Sterling Pharma Solutions
Sterling Pharma Solutions is a Healthcare company based in Dudley (United Kingdom) founded in 2016, and was acquired by GHO Capital Partners in February 2019. Contract development, manufacturing, and analytical services for APIs are offered. Sterling Pharma Solutions has completed 3 acquisitions, including ADC Biotechnology, CiVentiChem and NewChem Technologies. Its chief executive, as recorded, is Kevin Cook. Its website sterlingpharmasolutions.com draws about 12 thousand monthly visits. Sterling Pharma Solutions offers products and services including API Development, API Manufacturing, ADC Development, Peptide Manufacturing, and Analytical Services. Its focus areas include Biopharma Outsourcing, CDMO, Small Molecules & Peptides and API Production. Its legal entity is STERLING PHARMA SOLUTIONS LIMITED.
Company details
Sterling Pharma Solutions was established in 2016 in Dudley, United Kingdom. Operations focus on the pharmaceutical sector as a contract development and manufacturing organization (CDMO). Services encompass contract development, manufacturing, and analytical support specifically for active pharmaceutical ingredients (APIs). The company is led by CEO Kevin Cook and maintains its primary location in the UK to serve global clients in the industry.
- Headquarters Dudley, United Kingdom
- Stage Acquired
- SectorsHealthcare
- Website category Health · Biotechnology and Pharmaceuticals
- Website sterlingpharmasolutions.com
- Social LinkedIn Facebook YouTube
- Acquired by GHO Capital Partners (Feb 2019)
- Legal Name Sterling Pharma Solutions Limited
- Date of Incorporation 16 Feb, 2006
- Jurisdiction NORTHUMBERLAND
- InvestorsPartners Group
& 1 more
- Investments & AcquisitionsADC Biotechnology
& 2 more
- Acquired byGHO Capital Partners
(Feb 2019)
Products & Services of Sterling Pharma Solutions
Sterling Pharma Solutions offers a comprehensive portfolio of products and services, including API Development, API Manufacturing, ADC Development, Peptide Manufacturing, and Analytical Services.
Services for API route scouting and process optimization.
cGMP production of APIs including high-potency and hazardous compounds.
Support for ADC discovery, development, and clinical manufacturing.
Analysis, purification, and production of novel peptides.
Techniques like mass spectrometry for drug molecule evaluation.
Apps and channels of Sterling Pharma Solutions
its YouTube channel Sterling Pharma Solutions has 225 subscribers and 30 videos.
Videos from Sterling Pharma Solutions
The most watched videos on Sterling Pharma Solutions's YouTube channel, Sterling Pharma Solutions (225 subscribers). Click a video to play it here.
More on Sterling Pharma Solutions.
Funding Insights of Sterling Pharma Solutions
- Total Rounds 1
- Investors Count 2
All 1 funding rounds of Sterling Pharma Solutions with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| May 2023 | Seed | β | β |
2 investors in total: 2 institutional.
Investors in Sterling Pharma Solutions
Sterling Pharma Solutions has secured backing from 2 investors, including venture fund investors. Prominent investors backing the company include Partners Group and GHO Capital.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Specialist healthcare investment advisory services are provided by GHO Capital. | ghocapital.com | London, United Kingdom | ||
Private equity funds are managed across multiple sectors globally. | 1996 | partnersgroup.com | Baar, Switzerland |
Investor details for Sterling Pharma Solutions
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Sterling Pharma Solutions
193 people are tracked at Sterling Pharma Solutions (61 in leadership, 132 in team).
| Name | Role | Group |
|---|---|---|
Kevin Cook | CEO | Leadership |
Anne O'Sullivan | People & Organisation Business Partner | Leadership |
Karen Gallon | Head Of Quality | Leadership |
Andy Borthwick | Associate Director Facilities, Maintenance & Integration | Leadership |
Gary Chetcuti | Director Of Operations | Leadership |
Ian Lisle | Global Head Of Quality | Leadership |
Vagn Pedersen | Associate Director Of Supply Chain | Leadership |
Dr Anupama S. | Director, Business Development | Leadership |
Adam Kujath | Executive Vice President & Site Head | Leadership |
Paul Malone | Manufacturing Head | Leadership |
Lauren Youmans | Human Resources Business Partner | Leadership |
Alisha Arrigo | Business Development Director | Leadership |
Mathew Minardi | Executive Vice President Global Project Management | Leadership |
Tony Deehr | Director, EHS | Leadership |
Katie Crowley | Associate Director Of Project Management | Leadership |
Srinivas Battina | Associate Director | Leadership |
Matt Miklas | Associate Director, Technical Services | Leadership |
Niamh McDonnell | People And Organisation Business Partner | Leadership |
Joseph Culloty | Head Of Quality | Leadership |
Helen Stephenson | Director Environment, Health & Safety | Leadership |
173 more people are available in the full profile.
Complete people profiles for Sterling Pharma Solutions
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Sterling Pharma Solutions
Sterling Pharma Solutions has strategically engaged in corporate development activities, having acquired 3 companies. Notable acquisitions include ADC Biotechnology, CiVentiChem and NewChem Technologies.
| Company Name | Description | Domain | Location | Founded | Acquired | Amount |
|---|---|---|---|---|---|---|
NewChem Technologies is an chemical company specializing in commercial applications for organic chemistry. | newchemtechnologies.com | Durham, United Kingdom | 2002 | Oct 2023 | β’β’β’β’ | |
Developer of antibody drug conjugate (ADC) | adcbio.com | Saint Asaph, United Kingdom | 2010 | Apr 2021 | β’β’β’β’ | |
Contract research and manufacturing services are offered for pharmaceuticals. | civentichem.com | Cary, United States | 1994 | Apr 2019 | β’β’β’β’ |
Complete acquisition details for Sterling Pharma Solutions
Acquired stakes, deal sources and the complete acquisition history require an active premium plan.
- Acquired stakes
- Deal sources
- Complete history
- Exports
Verified entity values are shown only after access is granted.
Timeline of Sterling Pharma Solutions
6 dated milestones of Sterling Pharma Solutions across 7 years, from founding to its latest funding, stage changes and deals.
- Founded Sterling Pharma Solutions is founded.
- Exit Acquired by GHO Capital Partners.
- Acquisition Acquires CiVentiChem.
- Acquisition Acquires ADC Biotechnology.
- Funding First funding round.
- Acquisition Acquires NewChem Technologies.
Web traffic of Sterling Pharma Solutions
The website of Sterling Pharma Solutions (sterlingpharmasolutions.com) receives about 12.2K visits a month and ranks #2,060,032 among all websites worldwide, #2,806 in Biotechnology and Pharmaceuticals.
- Monthly visits12.2K
▲ 6.4% vs previous month
- Unique visitors4.6K
per month
- Global rank#2,060,032
among all websites
- Category rank#2,806
Health · Biotechnology and Pharmaceuticals
- Bounce rate49%
- Pages per visit1.8
- Average visit53 sec
- DevicesDesktop 52% Β· Mobile 48%
Websites whose visitors overlap most with Sterling Pharma Solutions. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
chiesiusa.com | chiesiusa.com | 100% | #1,397,563 | β | |
| rhoworld.com | 81% | 7.9K | #2,859,814 | View details | |
| novonordisk-us.com | 78% | 89K | #469,241 | View details | |
| catalent.com | 78% | 116.7K | #338,870 | View details | |
| ambiopharm.com | 78% | 15.1K | #1,550,315 | View details | |
| β’β’β’β’β’β’β’β’β’β’ | β’β’β’β’β’β’.com | β’β’% | β’.β’M | #β’β’β’β’β’ | β |
| β’β’β’β’β’β’β’β’β’β’ | β’β’β’β’β’β’.com | β’β’% | β’.β’M | #β’β’β’β’β’ | β |
All 7 similar websites and full traffic analytics for Sterling Pharma Solutions
The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.
- 7 similar websites
- Audience overlap
- Engagement analytics
- Traffic by brand
Verified entity values are shown only after access is granted.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track β from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Sterling Pharma Solutions
Complete news archive for Sterling Pharma Solutions
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Sterling Pharma Solutions
Sterling Pharma Solutions was founded in 2016 and raised its 1st funding round 7 years after it was founded.
Sterling Pharma Solutions is headquartered in Dudley, United Kingdom. It is registered at Dudley, West Midlands, United Kingdom.
Kevin Cook is the CEO of Sterling Pharma Solutions, as recorded in our data.
Sterling Pharma Solutions was established in 2016 in Dudley, United Kingdom. Operations focus on the pharmaceutical sector as a contract development and manufacturing organization (CDMO). Services encompass contract development, manufacturing, and analytical support specifically for active pharmaceutical ingredients (APIs). The company is led by CEO Kevin Cook and maintains its primary location in the UK to serve global clients in the industry.
Sterling Pharma Solutions offers API Development, API Manufacturing, ADC Development, Peptide Manufacturing, and Analytical Services.
Sterling Pharma Solutions has made 3 acquisitions, including ADC Biotechnology, CiVentiChem, and NewChem Technologies.
Sterling Pharma Solutions has 2 investors. Key investors include Partners Group, and GHO Capital.
Sterling Pharma Solutions operates through Sterling Pharma Solutions Limited.
Yes. Sterling Pharma Solutions was acquired by GHO Capital Partners in February 2019.

